In addition, significant upregulation of PD-L1, p-p65 and MHC-I were also observed in tumor tissues treated with the USP8 inhibitor or combined treatment compared with control treatment (Supplementary Fig. 6i–o). This evidence concerns the gene USP8 and neoplasm.